ArticleBlood and lymphatic cancer : targets and therapy2022

Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma.

Justin J Kuhlman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.